SCHEMBL7150200

SCHEMBL7150200

CCOC(=O)CCc1c(C(=O)OCC)[nH]c(C=C2C(=O)Nc3sccc32)c1CC(=O)OCC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 5/20 0.45
PDGFRB P09619 4/20 0.38
KDR P35968 3/20 0.38
RET P07949 3/20 0.38
FGFR1 P11362 3/20 0.38
FLT3 P36888 3/20 0.38
ALK Q9UM73 2/20 0.38
ABL1 P00519 1/20 0.38
AURKB Q96GD4 4/20 0.38
MAPK1 P28482 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CHEK1 O14757 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
HPGD P15428 1/20 0.35
MEN1 O00255 1/20 0.35
GAA P10253 1/20 0.35
TSHR P16473 1/20 0.35
ALOX12 P18054 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7150198 1.00 AURKA (0.45) AURKAPDGFRBKDRRETFGFR1
SCHEMBL5999815 0.84 AURKA (0.63) AURKAPDGFRBKDRRETFGFR1
SCHEMBL7154860 0.81 PDGFRB (0.49) AURKAPDGFRBKDRRETFGFR1
SCHEMBL7154856 0.81 PDGFRB (0.49) AURKAPDGFRBKDRRETFGFR1
SCHEMBL6001664 0.80 AURKA (0.63) AURKAPDGFRBKDRRETFGFR1
SCHEMBL8474631 0.79 AURKA (0.66) AURKAPDGFRBKDRRETFGFR1
SCHEMBL7136062 0.74 KMT2A (0.51) MAPK1SMN1; SMN2CYP1A2CYP2C9HPGD
SCHEMBL6405084 0.71 AURKA (0.54) AURKAPDGFRBKDRRETFGFR1
SCHEMBL6405087 0.71 AURKA (0.54) AURKAPDGFRBKDRRETFGFR1
SCHEMBL6406125 0.71 PDGFRB (0.62) AURKAPDGFRBKDRRETFGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6528653-B2 E.g., 4,6-dihydro 4-(heterocyclic ring-methylene)thieno(2,3-b) pyrrolidin-5-one derivatives; tumor necrosis factor ) inhibitors; anticarcinogenic, -proliferative and -arthritic agents; Alzheimer's disease; cardiovascular disorders HOFFMANN-LA ROCHE, INC. 2003-03-04 US disclosed